Arkadios Wealth Advisors’s Boston Scientific BSX Stock Holding History

Arkadios Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.92M	Buy	46,610 +1,850	+4%	+$148K	0.05%	395
2025 Q4	$4.27M	Buy	44,760 +7,024	+19%	+$689K	0.08%	257
2025 Q3	$3.68M	Buy	37,736 +16,996	+82%	+$1.76M	0.09%	240
2025 Q2	$2.23M	Buy	20,740 +1,606	+8%	+$162K	0.07%	319
2025 Q1	$1.93M	Buy	+19,134	New	+$1.93M	0.07%	291
2021 Q4	–	Sell	-356	Closed	-$15K	–	738
2021 Q3	$15K	Hold	356	–	–	﹤0.01%	1311
2021 Q2	$15K	Hold	356	–	–	﹤0.01%	1394
2021 Q1	$13K	Buy	+356	New	+$13.5K	﹤0.01%	1097
2020 Q3	–	Sell	-49	Closed	-$1.73K	–	1031
2020 Q2	$1.73K	Buy	49 +25	+104%	+$900	﹤0.01%	878
2020 Q1	$783	Buy	+24	New	+$938	﹤0.01%	985

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arkadios Wealth Advisors's BSX Position: Q1 2026 in Review

Arkadios Wealth Advisors increased its Boston Scientific (BSX) stake by 4.1% in Q1 2026, buying an estimated $148K and bringing the position to 46,610 shares worth $2.92M. The position accounts for 0.05% of the portfolio, ranked #395.

Arkadios Wealth Advisors first reported a position in BSX in Q1 2020 and has held it in 10 quarters since. The position peaked at $4.27M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Arkadios Wealth Advisors held 46,610 shares of Boston Scientific worth $2.92M as of Q1 2026.
Arkadios Wealth Advisors bought 1,850 Boston Scientific shares in Q1 2026, an estimated $148K.
Boston Scientific made up 0.05% of Arkadios Wealth Advisors's portfolio in Q1 2026, its #395 holding.
Arkadios Wealth Advisors first reported a position in Boston Scientific in Q1 2020 and has held it in 10 quarters since.
Arkadios Wealth Advisors's Boston Scientific position peaked at $4.27M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.